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CC BY-NC-ND license (http://creativSummary Cerebral hemangioblastomas are vascular tumors and rarely occur in supratentor-
ial locations. Here we present a case of a 52-year-old woman with a supratentorial hemangio-
blastoma mimicking a meningioma. Brain computed tomography and magnetic resonance
imaging revealed an intensely contrast-enhanced dural-based solid mass in the left frontal re-
gion. We demonstrate that vascular supratentorial hemangioblastomas can be resected with
limited blood loss through preoperative middle meningeal artery embolization.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Hemangioblastomas are predominantly present in the cer-
ebellum, brain stem, and spinal cord. They rarely occur in
supratentorial locations.1 These tumors may occur sporad-
ically or be associated with von HippeleLindau disease
(VHL).2,3 Here we report a case of a 52-year-old womanndicate no potential conflicts
of Medicine, Mackay Memo-
hongshan North Road, Taipei
l.com (S.-J. Chen).
02.002
Surgical Association. Published
ecommons.org/licenses/by-nc-ndwith a broad dural-based isolated supratentorial heman-
gioblastoma with hypervascular supply mimicking a
meningioma.
2. Case report
A 52-year-old, right-handed woman presented with short-
term alteration of consciousness after experiencing con-
vulsions. In addition, she experienced intermittent head-
aches and dizziness over the course of 1 month. She had no
family history of cancer or inherited diseases. Her physical
and neurological examinations upon admission were un-
remarkable. Hematological study results were within the
normal range. Brain computed tomography revealed an
intensely contrast-enhanced 4.2 cm  3.9 cm solid massby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1 Preoperative brain magnetic resonance imaging reveals a solid mass, approximately 3.9 cm  3.9 cm  2.5 cm, in the
left frontal high convexity: (A) with intense contrast enhancement; (B) coronal view; and (C) sagittal view showing evidence of a
dural-based intensely contrast-enhanced mass; (D, E) preoperative angiography was performed for therapeutic embolization; (F, G)
the devascularization was successful; (H, I) postoperative magnetic resonance imaging revealed no residual mass or recurrence.
Figure 2 Left frontal craniotomy was performed for tumor resection. The tumor was highly vascular and extrinsic and had a
defined border with the pia. The tumor and attached dura were resected en bloc.
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Figure 3 Histological sections. (A, B) A well-circumscribed brain tumor consisting of numerous branching capillary channels,
capillary venules, intervascular stromal cells, and lipoblast-like cells. The stromal cells are positive for: (C) neuron-specific enolase
(NSE); (D) CD56; (E) D2-40; and (F) factor VIII, and negative for CD31, CD34, S-100 protein, CD10, glial fibrillary acidic protein, and
alpha-inhibin.
80 C.-Y. Lee, S.-J. Chenwith perifocal edema in the left frontal area. Magnetic
resonance imaging (MRI) revealed that the tumor was
attached to the dura using intense contrast enhancement
(Figures 1Ae1C). Preoperative angiography was performed
for the therapeutic embolization of the hypervascular
tumor (Figures 1D and 1E). Successful devascularization of
the tumor via the left middle meningeal artery was per-
formed using 150e255-m polyvinyl alcohol particles
(Figures 1F and 1G). On the following day, left frontal
craniotomy was performed for tumor resection. The tumor
adhered to the dura with moderate vascularity, without
invading the brain parenchyma. The tumor and attached
dura were resected en bloc (Figure 2). Total blood loss
during the operation was 200 mL. Histopathological ex-
amination revealed numerous branching capillary chan-
nels, capillary venules, intervascular stromal cells, and
lipoblast-like cells. Immunostaining revealed that the
stromal cells were positive for neuron-specific enolase,CD56, D2-40, and factor VIII and negative for CD31, CD34,
S-100 protein, CD10, glial fibrillary acidic protein, and
alpha-inhibin (Figure 3). These findings were consistent
with the characteristics of hemangioblastomas. The pa-
tient recovered well after the operation. Follow-up MRI
4 months after the operation revealed no evidence of re-
sidual mass or recurrence (Figures 1H and 1I). Further-
more, a second follow-up MRI, 2 years after the operation
revealed no recurrence.
3. Discussion
Hemangioblastomas have been reported at various loca-
tions in the central nervous system. Supratentorial
hemangioblastomas are extremely rare. Between 1902 and
2013, approximately 132 cases of supratentorial heman-
gioblastomas were reported.4,5 In our patient, the tumor
was located in the left frontal area.
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lesions with a mural nodule. Solid tumors are less common
than cystic tumors are.6 Approximately seven cases of
isolated dural-based tumors were reported before
2007.6e8 In our patient, MRI revealed an intensely
contrast-enhanced, well circumscribed, broad, dural-
based lesion; its pattern resembled a meningioma with
perifocal edema.
The advantages of preoperative embolization remain
unclear. Cornelius et al9 observed a hemorrhage after the
particle embolization of a hemangioblastoma. Liu et al10
reported that the selective preoperative embolization of
a hemangioblastoma is a safe, effective, and reliable
adjuvant therapy for complete surgical resection of the
tumor. In our patient, preoperative angiography revealed
that the hemangioblastoma was mainly supplied by the
left middle meningeal artery and branches of the left
anterior and middle cerebral arteries. Successful preop-
erative devascularization was performed through the right
femoral arterial approach, and total blood loss during the
operation was only 200 mL. Blood loss majorly occurred
during craniotomy and not during tumor resection.
Therefore, preoperative embolization of a hemangio-
blastoma can minimize blood loss and shorten operation
time.
The recurrence rate of hemangioblastomas in patients
without VHL disease ranges from 5% to 17%.1,11,12 de la
Monte and Horowitz13 documented that an age <30 years
on initial diagnosis, presence of VHL disease, and multi-
centric involvement of the central nervous system
are independent predictors of hemangioblastoma
recurrence.11
Fukuda et al14 reported the recurrence of sporadic
cerebellar hemangioblastomas in four of 30 patients (13%)
at 6 months, 17 months, 6 years, and 22 years after oper-
ation. In our patient, a second follow-up brain MRI, 2 years
after the operation revealed no recurrence.
In conclusion, hemangioblastomas are rarely located in
supratentorial locations. Here we described the clinical
course of a 52-year-old woman with a hemangioblastoma
mimicking a meningioma in the left frontal lobe. We
demonstrate that vascular supratentorial hemangio-
blastomas can be successfully resected with limited blood
loss through preoperative middle meningeal artery
embolization.References
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